Caribbean External Quality Assurance Program in Bacteriology and Antimicrobial Resistance (PCC-CAR)
INFORMATIVE NEWSLETTER Nº 31 – May 2023
Dear Colleagues of the «Caribbean External Quality Assurance Program in Bacteriology and Antimicrobial Resistance»(PCC-CAR):
In the present newsletter we are sending you:
- CLSI 2023 News: summary of the most relevant news published in January 2023 in M100S 33rd Edition del Clinical Laboratory Standards Institute (CLSI): “Performance Standards for Antimicrobial Susceptibility Testing; Thirty third Informational Supplement”. M. Rapoport. http://antimicrobianos.com.ar/category/novedad_clsi/?
- The “Old” and the “New” Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How. Karaiskos I, Lagou S, Pontikis K,Rapti V and Poulakou G (2019). Front. Public Health 7:151.doi: 10.3389/fpubh.2019.00151
- Gentamicin Rationale for the EUCAST clinical breakpoints, version 2.0. EUCAST Rationale Document. Abril, 2020. https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Rationale_documents/Gentamicin_rationale_1.2_0906.pdf
- Tobramycin Rationale for the EUCAST clinical breakpoints, version 2.0. EUCAST Rationale Document. Abril, 2020. https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Rationale_documents/Tobramycin_rationale_1.2_0906.pdf
- Amikacin Rationale for the EUCAST clinical breakpoints, version 2.0. EUCAST Rationale Document. Abril, 2020. https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Rationale_documents/Amikacin_rationale_1.2_0906.pdf
Best regards and we will keep in touch!
Alejandra Corso and Paula Gagetti.
Servicio Antimicrobianos
Regional Reference Laboratory on Antimicrobial Resistance (RRL)
Instituto Nacional de Enfermedades Infecciosas
ANLIS «Dr. Carlos G. Malbrán».
Secretaria de Salud y Desarrollo Social
Av. Velez Sarsfield 563 (1281)
Buenos Aires, Argentina
+54 11 43032812